4D Molecular Therapeutics, Inc. - COM (FDMT)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
57.3M
Holdings value Q2 2024
$1.2B
Value change Q2 2024
+$3.26M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
138
Number of buys Q2 2024
80
Number of sells Q2 2024
-67
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 29.7K $321K +$321K $10.80 1
2024 Q2 57.3M $1.2B +$3.26M $20.99 139
2024 Q1 56.3M $1.79B +$451M $31.86 148
2023 Q4 42.4M $860M +$24.8M $20.26 112
2023 Q3 41.9M $534M +$5.22M $12.73 110
2023 Q2 41.2M $745M +$197M $18.07 100
2023 Q1 30.4M $522M +$35M $17.19 94
2022 Q4 28M $622M +$47.7M $22.21 97
2022 Q3 26.2M $210M +$1.97M $8.04 83
2022 Q2 26M $182M -$2.17M $6.98 86
2022 Q1 26.1M $395M +$20.4M $15.12 76
2021 Q4 24.7M $542M +$81.1M $21.94 77
2021 Q3 18.7M $505M +$57.5M $26.97 61
2021 Q2 16.6M $400M +$732K $24.08 54
2021 Q1 15.4M $665M +$34.1M $43.38 63
2020 Q4 14.6M $602M +$578M $41.45 51